Related Experiment Video
Updated: Jul 14, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Smad4-independent TGF-beta signaling in tumor cell migration
Klaudia Giehl1, Yukiko Imamichi, Andre Menke
1Institute of Pharmacology and Toxicology, University of Ulm Medical Center, Ulm, Germany. klaudia.giehl@uni-ulm.de
Abstract:
Transforming growth factor-beta (TGF-beta) belongs to a family of multifunctional growth factors that participates in the regulation of a variety of cellular activities. Beside induction of growth inhibition and differentiation of epithelial cells, TGF-beta has been shown to promote epithelial-mesenchymal transition in most epithelial tumors. While inhibition of epithelial cell proliferation in response to TGF-beta is mainly mediated by the well-characterized Smad pathway and subsequent inhibition of gene transcription, the molecular mechanism leading to TGF-beta-induced invasiveness and metastasis of epithelial tumors is less clear. Recent results from several groups suggest that the induction of tumorigenic activity by TGF-beta includes not only signaling by Smads, but also by Rho-GTPases and mitogen-activated protein kinases (MAP kinases). Activation of the MAP kinases extracellular signal-regulated kinases (ERK) 1 and 2 as well as c-jun N-terminal kinase (JNK) has been identified as important steps in TGF-beta-induced, Smad4-independent signal transduction in epithelial cells. Recent results identify a role of activated ERK and JNK and their association with focal complexes in TGF-beta-induced, Smad4-independent cell migration of breast carcinoma cells, and are reviewed here.
Insights
Transforming growth factor-beta (TGF-beta) promotes cancer cell migration via Smad4-independent pathways. Activated MAP kinases, ERK and JNK, are key players in this TGF-beta-induced tumor invasiveness.
Area of Science:
- Cell Biology
- Molecular Oncology
- Cancer Research
Background:
- Transforming growth factor-beta (TGF-beta) regulates diverse cellular functions, including epithelial cell proliferation and differentiation.
- While TGF-beta inhibits epithelial cell growth via the Smad pathway, its role in promoting epithelial-mesenchymal transition, invasiveness, and metastasis in tumors is less understood.
- Tumorigenic activity induced by TGF-beta involves signaling pathways beyond Smads, including Rho-GTPases and MAP kinases.
Purpose of the Study:
- To review the molecular mechanisms underlying TGF-beta-induced epithelial tumor invasiveness and metastasis.
- To highlight the role of MAP kinases, specifically ERK and JNK, in TGF-beta-mediated cell migration.
- To discuss the Smad4-independent signaling pathways involved in TGF-beta's pro-tumorigenic effects.
Main Methods:
- Review of recent scientific literature and experimental findings.
- Analysis of signaling pathways, including Smad, Rho-GTPases, and MAP kinases (ERK, JNK).
- Focus on Smad4-independent signal transduction in epithelial cells, particularly breast carcinoma cells.
Main Results:
- Activation of extracellular signal-regulated kinases (ERK) 1/2 and c-jun N-terminal kinase (JNK) are critical for TGF-beta-induced, Smad4-independent signal transduction.
- Activated ERK and JNK associate with focal complexes, mediating TGF-beta-induced cell migration in breast carcinoma cells.
- These findings suggest a significant role for MAP kinases in TGF-beta's promotion of tumor invasiveness.
Conclusions:
- TGF-beta-induced tumor cell migration and metastasis involve Smad4-independent signaling pathways.
- MAP kinases (ERK and JNK) are crucial mediators of TGF-beta's pro-migratory effects in epithelial tumors.
- Understanding these pathways offers potential therapeutic targets for inhibiting cancer progression.
Related Concept Videos
TGF - β Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...
Cell Migration
Cell Migration
Cancer Cell Migration through Invadopodia
The Tumor Microenvironment

